EVIO Inc. (“EVIO” or the “Company”), (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry, is pleased to announce that it has received an approval from Health Canada on an amendment of its Dealer License that will expand the product and service offering for EVIO Canada’s Keystone Labs in Edmonton effective August 24, 2018.
September 10, 2018
· 3 min read